Navigation Links
Genta Receives Key Patent Related to Oral Gallium Compound G4544
Date:4/14/2008

. Ganite is exclusively marketed in the U.S. by Genta and is available to patients outside the U.S. on a "named-patient" basis.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its DNA/RNA Medicines program. Genta is currently recruiting patients to the AGENDA Trial, a global Phase 3 trial of Genasense in patients with advanced melanoma. The leading drug in Genta's Small Molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. The Company has developed G4544, an oral formulation of the active ingredient in Ganite, that has recently entered clinical trials as a potential treatment for diseases associated with accelerated bone loss. The Company is also developing tesetaxel, a novel, orally absorbed, semi- synthetic taxane that is in the same class of drugs as paclitaxel and docetaxel. Ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our website at: http://www.genta.com.

Safe Harbor

This press release may contain forward-looking statements with respect to business conducted by Genta Incorporated. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Forward- looking statements include, without limitation, statements about:

-- the Company's ability to obtain necessary regulatory app
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
2. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
3. Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
4. Genta Incorporated Announces Third Quarter 2007 Financial Results
5. Genta Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases
6. Genta Clinical Programs Featured at American Society of Hematology Meeting
7. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
8. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
9. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
10. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
11. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 2015   VWR  (NASDAQ:  VWR), a leading, ... announced today the expansion of its distribution agreement ... allows VWR increased access to NEB,s growing product ... and Puerto Rico.  In addition, customers will now ... platform, sales organization, and VWRCATALYST, our onsite services ...
(Date:3/3/2015)...  The eleventh annual Tucson Symposium will be held ... research scientists, academics, oncologists and pathologists will gather to ... new outcomes in patient treatments that may significantly affect ... Ventana Medical Systems, Inc. (Ventana), a member of ... at the Hilton El Conquistador in Tucson, ...
(Date:3/3/2015)... and NEW YORK , March ... PTBI ), a biopharmaceutical company advancing protein biologic therapies ... present at the 27 th Annual ROTH Capital ... 2015, at The Ritz-Carlton, Laguna Niguel in Dana Point, ... Harrison Wehner , is scheduled to present a corporate ...
Breaking Medicine Technology:VWR Announces Expansion of Distribution Agreement with New England Biolabs 2Global scientific collaborators to explore latest pathology and oncology advancements at Tucson Symposium 2PlasmaTech Biopharmaceuticals To Present at 27th Annual ROTH Capital Partners Conference 2
... May 17, 2012 Telepharmacy is helping pharmacies ... and alleviate staffing shortages experienced by many rural ... States. Telepharmacy allows for a pharmacy technician to ... pharmacist through state-of-the-art telecommunications technology to prepare prescriptions. ...
...  Mylan Inc. (Nasdaq: MYL ) today announced that ... the U.S. Food and Drug Administration (FDA) for its Abbreviated ... and 300 mg. The company was the first to have ... to the FDA for Clopidogrel Tablets, 300 mg, and was ...
Cached Medicine Technology:Rural Health-Systems Benefit From Remote Pharmacy Technician Supervision 2Rural Health-Systems Benefit From Remote Pharmacy Technician Supervision 3Mylan Launches Generic Version of Plavix® Tablets 2
(Date:3/3/2015)... Mansfield, Texas (PRWEB) March 03, 2015 ... natural childbirth, announced today they now have over 130 ... Canada and 1 in Germany. In addition, the company ... joining their existing childbirth educator certification program . ... both mom and her birth partner. The practical information ...
(Date:3/3/2015)... March 3, 2015, My Positive Perspective host was ... was a unique one, not just because it was the ... two men who were both faced with monumental obstacles after ... the episode, Deierlein said to Collins, “I had the opportunity ... I’m very excited that you could join me on the ...
(Date:3/3/2015)... Wisconsin (PRWEB) March 03, 2015 Presale tickets ... Onsales to the general public begin on March 9, with ... the globe. Every tour performed by the talented artist is ... will be no exception. , Visit Ticketability.com to ... With a new album for fans to enjoy, the 2015 ...
(Date:3/3/2015)... Venato, a secure cloud-based credential ... flagship software solution now provides an automated mechanism ... to the National Healthcare Safety Network (NHSN). ... require that hospitals submit healthcare personnel (HCP) influenza ... May 15 for each influenza season in order ...
(Date:3/3/2015)... 03, 2015 Chicago has long been known ... Michael Jordan, brought a level of basketball to Chicago that ... experience again since his Chicago Bulls days in the 1990’s. ... to this day. This era also witnessed the birth and ... Due to this rich basketball culture, US Sports Camps seeks ...
Breaking Medicine News(10 mins):Health News:Expectant Couples Worldwide Can Now Receive Training and Education in Natural Childbirth and Breastfeeding from Birth Boot Camp 2Health News:My Positive Perspective Releases Episode #200 With Car Accident and Coma Survivor Nick Collins 2Health News:Presale Tickets for Madonna: Ticketability.com Announces Madonna Tour Tickets for Sale at Reduced Prices for the Rebel Heart Tour During Presales 2Health News:Venato Incorporates Automated NHSN Reporting Tool to Their Software Solution 2Health News:US Sports Camps and Nike Basketball Camps Add Five New Locations In and Around Chicago for the Summer of 2015 2
... could point to novel therapies to prevent cancer spread, or ... School of Medicine have targeted a sugar that supports ... is the most common cause of cancer death and an ... according to first author Mark M. Fuster, M.D., assistant professor ...
... recognition of ecotherapy as a clinically-valid frontline treatment for mental ... show the therapy is effective. ,Mind, a leading ... mental health. It has released a report saying that 71 ... cent report depression increase after urban walk. ,Backed ...
... the National Institutes of Health has awarded Emory University ... to test schizophrenic patients for a recently discovered variation ... Stephen T. Warren, PhD, Timmie Professor and chair of ... a severe and common psychiatric disorder that has a ...
... women with a history of migraine and other headaches are ... the eye which can lead to severe vision problems ... to a study published in the May 15, 2007, issue ... Neurology. ,For the study, researchers reviewed the headache ...
... news for the horizontally inclined. An American inventor has ... walk, and lose weight , while working at the ... Rochester, Minn., who designed the standup "walk-and-work" desk, suggest ... perform what are traditionally sit-down tasks. The workstation can ...
... study of 62 youngsters has revealed that low tar, low ... as regular cigarettes . ,All the participants in ... were in their mid-twenties. ,Twenty of them had ... years, while 20 other participants had smoked regular cigarettes for ...
Cached Medicine News:Health News:Targeting Sugar on Blood Vessels may Inhibit Cancer Growth 2Health News:Now a Green Agenda for Mental Health 2Health News:Now a Green Agenda for Mental Health 3Health News:Now a Green Agenda for Mental Health 4Health News:NIH Awards Emory $3.6 Million for Schizophrenia Gene Research 2Health News:Mid-Life Headaches May Increase Risk of Vision Problems 2Health News:Stand Up And Get Back To Work! 2
... GEs premier digital cardiovascular system that brings ... echocardiography, and a new dimension of comfort ... customer input, using Six Sigma practices, GE ... that delivers what customers want: Better image ...
... Radi invented the guidewire-mounted pressure sensor ... PressureWire5 Sensor is the only sensor ... temperature and flow. With significantly improved ... as your primary guidewire, as well ...
The Androscope i-stethos is the next revolution in electronic auscultation. Plus, the ability to filter out ambient sounds, so healthcare professionals even those in noisy places like the ER could ...
... the best EMR value for many medical ... Charting Plus™ relies heavily on a user-friendly ... improve documentation quality and increase productivity in ... specific to your medical specialty. Each program ...
Medicine Products: